Disease Markers / 2020 / Article / Tab 2 / Review Article
The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis Table 2 Subgroup analysis and metaregression of the studies reporting the effect of F-NLR score in OS.
Stratified study No. of studies Pooled HR (95% CI) Heterogeneity Metaregression (%) valueTau2 Adj (%) valueCancer type 0.04 -11.81 0.77 Digestive system 7 1.817 (1.497-2.206) 0 0.77 NSCLC 4 1.65 (1.266-2.15) 81.9 <0.01 Other type 1 2.103 (1.401-3.156) — — Publication year 0.03 15.36 0.23 ≥2017 7 1.683 (1.389-2.04) 69.3 <0.01 <2017 5 2.121 (1.598-2.817) 0 0.97 Sample size 0.03 29.73 0.11 7 2.105 (1.684-2.631) 0 0.99 5 1.618 (1.307-2.004) 76 <0.01 Country 0.03 8.8 0.36 China 7 1.715 (1.406-2.092) 71.6 <0.01 Japan 5 2.04 (1.531-2.718) 0 0.99 Analysis type 0.03 6.9 0.37 Multivariate 7 1.676 (1.371-2.049) 58.9 0.02 Univariate 5 1.909 (1.608-2.267) 0 0.43 Gender (Female, %) 0.02 44.22 0.1 >31 7 1.617 (1.35-1.937) 56.7 0.03 ≤31 5 2.12 (1.739-2.585) 0 0.98 Age (year) 0.04 -12.82 0.61 >60 8 1.742 (1.389-2.184) 61.4 0.01 ≤60 4 1.874 (1.445-2.432) 46.7 0.13